April 16, 2026
Sanity Group
Organigram Global and Sanity Group Announce Successful Closing of Acquisition
Press & Media hub
Media Kit
Sanity Group digital press release PDF includes: About the company, factsheet, quotes and portraits (only available in German).
Logo
Sanity Group's Logo (JPG, PNG, PDF) includes: Logo Horizontal (default), Logo Reversed (White), Logo Centered.
Founders Profiles
Short biographies & careers of Sanity Group founders Finn Hänsel and Fabian Friede (available in German and English).
Press Photos
Sanity Group's press images high and web resolution folder includes: Office & Labs, Founders, Management Team, Sanity Group Staff, Endosane Pharmaceuticals Staff, Belfry Medical Staff, Sanity Group Brands (product images & logos).
Latest News
April 1, 2026
Sanity Group
Evaluation Report on Second Anniversary of German Cannabis Act: Sanity Group Calls for Evidence-Based Regulation
March 23, 2026
Sanity Group
Sanity Group and Curaleaf Laboratories Announce Partnership to Advance Medical Cannabis Innovation in the UK
February 18, 2026
Sanity Group
Sanity Group Becomes Part of Canadian Cannabis Market Leader Organigram Global to Drive International Growth
February 8, 2026
Sanity Group
Two Years of Legal Cannabis from Specialized Retail Stores: Swiss Pilot Project Shows Positive Effects on Health Protection, Consumer Competence, and ...
In the media
March 23, 2026
vayamed
Big Tobacco Jumps Into Germany’s Pot Industry alongside Snoop Dogg
March 23, 2026
Vaay
Big Tobacco Jumps Into Germany’s Pot Industry alongside Snoop Dogg
March 23, 2026
Sanity Group
Big Tobacco Jumps Into Germany’s Pot Industry alongside Snoop Dogg
Interested in covering Sanity Group?
About Sanity Group
At Sanity Group, we pursue a clear goal: Unlock the full health potential of cannabinoids
Sanity Group was founded in Berlin in 2018 by Finn Hänsel (Founder & CEO) and Fabian Friede (Founder & Addvisor).
The Berlin-based health and life science company aims to improve people’s quality of life by harnessing the potential of cannabinoids and the endocannabinoid system. Our work focuses on medical cannabis products, research on finished pharmaceuticals and cannabinoid-based consumer goods
The Berlin-based health and life science company aims to improve people’s quality of life by harnessing the potential of cannabinoids and the endocannabinoid system. Our work focuses on medical cannabis products, research on finished pharmaceuticals and cannabinoid-based consumer goods
“It’s important to understand the full potential of the plant – that’s what we’re working for, to bring cannabis back to the center of European society.”
Finn Hänsel
Founder and Chief Executive Officer
Our brands
An overview of our brands in medical cannabis, scientific pilot projects on recreational cannabis and CBD products.
ZOIKS - aims to improve patient care with high-quality medicinal cannabis through particularly affordable medicines.
avaay Medical supplies patients through pharmacies with high-quality cannabis medicines - for a individualized therapy with natural products.
Vayamed is a fully licensed pharmaceutical company that distributes medical cannabis medicines to pharmacies and clinical facilities - focusing on the supply to patients with statutory health insurance.
Grashaus Projects is an official pilot project for recreational cannabis in Switzerland, investigating the effects of the legal sale of THC-containing products on the consumption behaviour of study participants.
vaay positions itself as the "wellbeing brand" of the Sanity Group, focusing on CBD products in the fields of cosmetics, dietary supplements, and lifestyle.
